CVE-2015-3965
3Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackepss 2.9%
exploitation probability
2.9%top 14% of all CVEs
observed exploitation
nono source reports it
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
Affected products
Hospira · Symbiq Infusion System